1. Home
  2. FSTR vs LUNG Comparison

FSTR vs LUNG Comparison

Compare FSTR & LUNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo L.B. Foster Company

FSTR

L.B. Foster Company

N/A

Current Price

$28.14

Market Cap

270.6M

Sector

Industrials

ML Signal

N/A

Logo Pulmonx Corporation

LUNG

Pulmonx Corporation

HOLD

Current Price

$2.22

Market Cap

63.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FSTR
LUNG
Founded
1902
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Industrial Specialties
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
270.6M
63.6M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
FSTR
LUNG
Price
$28.14
$2.22
Analyst Decision
Buy
Analyst Count
0
7
Target Price
N/A
$6.81
AVG Volume (30 Days)
30.4K
1.1M
Earning Date
11-03-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.44
N/A
Revenue
$507,819,000.00
$91,664,000.00
Revenue This Year
$3.42
$9.21
Revenue Next Year
$3.88
$5.03
P/E Ratio
$63.39
N/A
Revenue Growth
N/A
15.59
52 Week Low
$17.16
$1.31
52 Week High
$29.42
$9.37

Technical Indicators

Market Signals
Indicator
FSTR
LUNG
Relative Strength Index (RSI) 54.59 53.49
Support Level $28.00 $2.43
Resistance Level $29.30 $2.65
Average True Range (ATR) 1.01 0.21
MACD 0.11 -0.00
Stochastic Oscillator 54.72 48.15

Price Performance

Historical Comparison
FSTR
LUNG

About FSTR L.B. Foster Company

L.B. Foster Co is a U.S-based firm engaged in the manufacturing, fabrication, and distribution of products and services, especially for the rail, construction, energy, and utility industries. The company operates its business through two segments: Rail Technologies and Services and Infrastructure Solutions. Its principal business activity involves providing new and used rail, trackwork, and accessories, producing concrete railroad ties, insulated rail joints, power rail, track fasteners, cover boards, and sales of sells and rents steel sheet piling, H-bearing pile, and other piling products for foundation and earth retention requirements. It generates the majority of its revenues from the Rail Technologies and Services segment.

About LUNG Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.

Share on Social Networks: